CompletedEarly Phase 1NCT03080051
Evaluation of [18F]MNI-952 as a Potential PET Radioligand for Imaging Tau Protein in the Brain
Studying Classic progressive supranuclear palsy syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Molecular NeuroImaging
- Principal Investigator
- Jennifer Madonia, PA-CMolecular NeuroImaging
- Intervention
- [18F]MNI-952(drug)
- Enrollment
- 6 enrolled
- Eligibility
- 18-90 years · All sexes
- Timeline
- 2016 – 2017
Study locations (1)
- Molecular NeuroImaging, LLC, New Haven, Connecticut, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03080051 on ClinicalTrials.govOther trials for Classic progressive supranuclear palsy syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07509125Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic DisordersUniversitaire Ziekenhuizen KU Leuven
- RECRUITINGEARLY PHASE1NCT07348276First-in-Human Study for the Safety and Evaluation of Two 4R Tau Ligands as Potential PET Radioligands for Imaging Tau Protein in the BrainInvicro
- RECRUITINGNANCT07291687tDCS as Treatment for Motor FunctionBaycrest
- ACTIVE NOT RECRUITINGNANCT06588673Art Therapy in Progressive Supranuclear PalsyVanderbilt University Medical Center
- ENROLLING BY INVITATIONNANCT06597071Parkinson Atypical Rating of Oculometric Patterns Evaluated RoutinelyNeuraLight
- ACTIVE NOT RECRUITINGPHASE2NCT06355531A Study to Assess the Efficacy, Safety, and Pharmacokinetics of FNP-223 to Slow Progression of Progressive Supranuclear Palsy (PSP)Ferrer Internacional S.A.
- RECRUITINGNCT06949865AI-Enhanced Optimization of Acute Levodopa Challenge TestBeijing Tiantan Hospital
- RECRUITINGNANCT06174948The Use of the CUE1/CUE1+ in People With Parkinson's Disease and Related DisordersQueen Mary University of London
See all trials for Classic progressive supranuclear palsy syndrome →